Miniatura

Fitxers

647634.pdf (2.92 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2014-02-01

Llicència de publicació

cc-by (c) Kalko, Susana et al., 2014
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/113597

Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1186/1471-2164-15-91

Resum

BACKGROUND: Mutations in the gene encoding thymidine kinase 2 (TK2) result in the myopathic form of mitochondrial DNA depletion syndrome which is a mitochondrial encephalomyopathy presenting in children. In order to unveil some of the mechanisms involved in this pathology and to identify potential biomarkers and therapeutic targets we have investigated the gene expression profile of human skeletal muscle deficient for TK2 using cDNA microarrays. RESULTS: We have analysed the whole transcriptome of skeletal muscle from patients with TK2 mutations and compared it to normal muscle and to muscle from patients with other mitochondrial myopathies. We have identified a set of over 700 genes which are differentially expressed in TK2 deficient muscle. Bioinformatics analysis reveals important changes in muscle metabolism, in particular, in glucose and glycogen utilisation, and activation of the starvation response which affects aminoacid and lipid metabolism. We have identified those transcriptional regulators which are likely to be responsible for the observed changes in gene expression. CONCLUSION: Our data point towards the tumor suppressor p53 as the regulator at the centre of a network of genes which are responsible for a coordinated response to TK2 mutations which involves inflammation, activation of muscle cell death by apoptosis and induction of growth and differentiation factor 15 (GDF-15) in muscle and serum. We propose that GDF-15 may represent a potential novel biomarker for mitochondrial dysfunction although further studies are required.

Matèries

Expressió gènica, Bioinformàtica, Microxips d'ADN, ADN mitocondrial, Apoptosi, Malalties del sistema nerviós central, Infants

Matèries (anglès)

Gene expression, Bioinformatics, DNA microarrays, Mitochondrial DNA, Apoptosis, Central nervous system diseases, Children

Citació

Col·leccions

Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Biomedicina)
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

KALKO, Susana, PACO MERCADER, Sonia, JOU, Cristina, RODRÍGUEZ, María angeles, MEZNARIC, Marija, ROGAC, Mihael, JEKOVEC-VRHOVSEK, Maja, SCIACCO, Monica, MOGGIO, Maurizio, FAGIOLARI, Gigliola, DE PAEPE, Boel, DE MEIRLEIR, Linda, FERRER, Isidro (ferrer abizanda), ROIG QUILIS, Manuel, MUNELL CASADESÚS, Francina, MONTOYA, Julio, LÓPEZ GALLARDO, Ester, RUIZ PESINI, Eduardo, ARTUCH IRIBERRI, Rafael, MONTERO SÁNCHEZ, Raquel, TORNER RUBIES, Ferran, NASCIMENTO, Andrés, ORTEZ, Carlos ignacio, COLOMER OFERIL, Jaume, JIMÉNEZ MALLEBRERA, Cecilia. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. _Bmc Genomics_. 2014. Vol. 15, núm. 91. [consulta: 23 de gener de 2026]. ISSN: 1471-2164. [Disponible a: https://hdl.handle.net/2445/113597]

Exportar metadades

JSON - METS

Compartir registre